Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism BRD4 inhibitors(Bromodomain-containing protein 4 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC23H27F3N4O4S |
InChIKeyZPMULUKHFNMJPF-FQEVSTJZSA-N |
CAS Registry2230496-99-6 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Inflammation | Preclinical | US | 10 Feb 2022 |